133 related articles for article (PubMed ID: 34258920)
21. Role of matrix metalloproteinases and their tissue inhibitor of metalloproteinases in myxomatous change of cardiac floppy valves.
Togashi M; Tamura K; Nitta T; Ishizaki M; Sugisaki Y; Fukuda Y
Pathol Int; 2007 May; 57(5):251-9. PubMed ID: 17493172
[TBL] [Abstract][Full Text] [Related]
22. Culture and characterisation of canine mitral valve interstitial and endothelial cells.
Liu MM; Flanagan TC; Lu CC; French AT; Argyle DJ; Corcoran BM
Vet J; 2015 Apr; 204(1):32-9. PubMed ID: 25747697
[TBL] [Abstract][Full Text] [Related]
23. Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation.
Caira FC; Stock SR; Gleason TG; McGee EC; Huang J; Bonow RO; Spelsberg TC; McCarthy PM; Rahimtoola SH; Rajamannan NM
J Am Coll Cardiol; 2006 Apr; 47(8):1707-12. PubMed ID: 16631011
[TBL] [Abstract][Full Text] [Related]
24. Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart.
Soini Y; Satta J; Määttä M; Autio-Harmainen H
J Pathol; 2001 Jun; 194(2):225-31. PubMed ID: 11400152
[TBL] [Abstract][Full Text] [Related]
25. Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors.
Fondard O; Detaint D; Iung B; Choqueux C; Adle-Biassette H; Jarraya M; Hvass U; Couetil JP; Henin D; Michel JB; Vahanian A; Jacob MP
Eur Heart J; 2005 Jul; 26(13):1333-41. PubMed ID: 15827062
[TBL] [Abstract][Full Text] [Related]
26. Tumor necrosis factor alpha and interleukin 1 beta suppress myofibroblast activation via nuclear factor kappa B signaling in 3D-cultured mitral valve interstitial cells.
Zhu AS; Mustafa T; Connell JP; Grande-Allen KJ
Acta Biomater; 2021 Jun; 127():159-168. PubMed ID: 33831572
[TBL] [Abstract][Full Text] [Related]
27. A Role for MMP-10 (Matrix Metalloproteinase-10) in Calcific Aortic Valve Stenosis.
Matilla L; Roncal C; Ibarrola J; Arrieta V; García-Peña A; Fernández-Celis A; Navarro A; Álvarez V; Gainza A; Orbe J; Cachofeiro V; Zalba G; Sádaba R; Rodríguez JA; López-Andrés N
Arterioscler Thromb Vasc Biol; 2020 May; 40(5):1370-1382. PubMed ID: 32188274
[TBL] [Abstract][Full Text] [Related]
28. Identification of CD34+/PGDFRα+ Valve Interstitial Cells (VICs) in Human Aortic Valves: Association of Their Abundance, Morphology and Spatial Organization with Early Calcific Remodeling.
Lis GJ; Dubrowski A; Lis M; Solewski B; Witkowska K; Aleksandrovych V; Jasek-Gajda E; Hołda MK; Gil K; Litwin JA
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32878299
[TBL] [Abstract][Full Text] [Related]
29. Modulation of transforming growth factor-β signaling and extracellular matrix production in myxomatous mitral valves by angiotensin II receptor blockers.
Geirsson A; Singh M; Ali R; Abbas H; Li W; Sanchez JA; Hashim S; Tellides G
Circulation; 2012 Sep; 126(11 Suppl 1):S189-97. PubMed ID: 22965982
[TBL] [Abstract][Full Text] [Related]
30. Simulation of early calcific aortic valve disease in a 3D platform: A role for myofibroblast differentiation.
Hjortnaes J; Goettsch C; Hutcheson JD; Camci-Unal G; Lax L; Scherer K; Body S; Schoen FJ; Kluin J; Khademhosseini A; Aikawa E
J Mol Cell Cardiol; 2016 May; 94():13-20. PubMed ID: 26996755
[TBL] [Abstract][Full Text] [Related]
31. Valvular interstitial cells suppress calcification of valvular endothelial cells.
Hjortnaes J; Shapero K; Goettsch C; Hutcheson JD; Keegan J; Kluin J; Mayer JE; Bischoff J; Aikawa E
Atherosclerosis; 2015 Sep; 242(1):251-260. PubMed ID: 26232165
[TBL] [Abstract][Full Text] [Related]
32. Profile and localization of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in human heart valves.
Dreger SA; Taylor PM; Allen SP; Yacoub MH
J Heart Valve Dis; 2002 Nov; 11(6):875-80; discussion 880. PubMed ID: 12479292
[TBL] [Abstract][Full Text] [Related]
33. Transforming growth factor-β1 promotes fibrosis but attenuates calcification of valvular tissue applied as a three-dimensional calcific aortic valve disease model.
Jenke A; Kistner J; Saradar S; Chekhoeva A; Yazdanyar M; Bergmann AK; Rötepohl MV; Lichtenberg A; Akhyari P
Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H1123-H1141. PubMed ID: 32986963
[TBL] [Abstract][Full Text] [Related]
34. TRPV1 Receptor Identification in Bovine and Canine Mitral Valvular Interstitial Cells.
Vercelli C; Gambino G; Amadori M; Re G; Martignani E; Barberis RV; Janus I; Tursi M
Vet Sci; 2021 Sep; 8(9):. PubMed ID: 34564577
[TBL] [Abstract][Full Text] [Related]
35. Interleukin 18 promotes myofibroblast activation of valvular interstitial cells.
Zhou J; Zhu J; Jiang L; Zhang B; Zhu D; Wu Y
Int J Cardiol; 2016 Oct; 221():998-1003. PubMed ID: 27441481
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of canine 2D cell cultures as models of myxomatous mitral valve degeneration.
Tan K; Markby G; Muirhead R; Blake R; Bergeron L; Fici G; Summers K; Macrae V; Corcoran B
PLoS One; 2019; 14(8):e0221126. PubMed ID: 31415646
[TBL] [Abstract][Full Text] [Related]
37. Association of matrix metalloproteinase 3 and endogenous inhibitors with inflammatory markers in mitral valve disease and calcification.
Aloui S; Zidi W; Ouali S; Guizani I; Hadj-Taieb S; Mourali MS; Feki M; Allal-Elasmi M
Mol Biol Rep; 2018 Dec; 45(6):2135-2143. PubMed ID: 30302620
[TBL] [Abstract][Full Text] [Related]
38. Expression and activity of matrix metalloproteinase-2 in calcific aortic stenosis.
Kaden JJ; Vocke DC; Fischer CS; Grobholz R; Brueckmann M; Vahl CF; Hagl S; Haase KK; Dempfle CE; Borggrefe M
Z Kardiol; 2004 Feb; 93(2):124-30. PubMed ID: 14963678
[TBL] [Abstract][Full Text] [Related]
39. Role for Galectin-3 in Calcific Aortic Valve Stenosis.
Sádaba JR; Martínez-Martínez E; Arrieta V; Álvarez V; Fernández-Celis A; Ibarrola J; Melero A; Rossignol P; Cachofeiro V; López-Andrés N
J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27815266
[TBL] [Abstract][Full Text] [Related]
40. Glycosaminoglycan profiles of myxomatous mitral leaflets and chordae parallel the severity of mechanical alterations.
Grande-Allen KJ; Griffin BP; Ratliff NB; Cosgrove DM; Vesely I
J Am Coll Cardiol; 2003 Jul; 42(2):271-7. PubMed ID: 12875763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
